Antiretroviral treatment interruption among people living with HIV during COVID‐19 outbreak in China: a nationwide cross‐sectional study
Open Access
- 28 October 2020
- journal article
- research article
- Published by Wiley in Journal of the International AIDS Society
- Vol. 23 (11) , e25637
Abstract
Introduction: Social disruption associated with coronavirus disease 2019 (COVID‐19) threatens to impede access to regular healthcare, including for people living with HIV (PLHIV), potentially resulting in antiretroviral therapy (ART) interruption (ATI). We aimed to explore the characteristics and factors associated with ATI during the COVID‐19 outbreak in China.Methods: We conducted an online survey among PLHIV by convenience sampling through social media between 5 and 17 February 2020. Respondents were asked to report whether they were at risk of ATI (i.e. experienced ATI, risk of imminent ATI, threatened but resolved risk of ATI [obtaining ART prior to interruption]) or were not at risk of ATI associated with the COVID‐19 outbreak. PLHIV were also asked to report perceived risk factors for ATI and sources of additional ART. The factors associated with the risk of ATI were assessed using logistic regression. We also evaluated the factors associated with experienced ATI.Results: A total of 5084 PLHIV from 31 provinces, autonomous regions and municipalities in mainland China completed the survey, with valid response rate of 99.4%. The median age was 31 years (IQR 27 to 37), 96.5% of participants were men, and 71.3% were men who had sex with men. Over one‐third (35.1%, 1782/5084) reported any risk of ATI during the COVID‐19 outbreak, including 2.7% (135/5084) who experienced ATI, 18.0% (917/5084) at risk of imminent ATI and 14.4% (730/5084) at threatened but resolved risk. PLHIV with ATI were more likely to have previous interruptions in ART (aOR 8.3, 95% CI 5.6 to 12.3), travelled away from where they typically receive HIV care (aOR 3.0, 95% CI 2.1 to 4.5), stayed in an area that implemented citywide lockdowns or travel restrictions to control COVID‐19 (aOR 2.5, 95% CI 1.4 to 4.6), and be in permanent residence in a rural area (aOR 3.7, 95% CI 2.3 to 5.8).Conclusions: A significant proportion of PLHIV in China are at risk of ATI during the COVID‐19 outbreak and some have already experienced ATI. Correlates of ATI and self‐reported barriers to ART suggest that social disruptions from COVID‐19 have contributed to ATI. Our findings demonstrate an urgent need for policies and interventions to maintain access to HIV care during public health emergencies.Keywords
Funding Information
- National Major Science and Technology Projects of China (2018ZX10721102)
This publication has 13 references indexed in Scilit:
- Maintaining HIV care during the COVID-19 pandemicThe Lancet HIV, 2020
- History of the HIV Epidemic in ChinaCurrent HIV/AIDS Reports, 2019
- The Multipurpose Application WeChat: A Review on Recent ResearchFrontiers in Psychology, 2018
- HIV risks and needs related to the Sustainable Development Goals among female sex workers who were commercially sexually exploited as children in LesothoJournal of the International AIDS Society, 2018
- The Human Immunodeficiency Virus Care Continuum in China: 1985–2015Clinical Infectious Diseases, 2017
- High rates of unplanned interruptions from HIV care early after antiretroviral therapy initiation in NigeriaBMC Infectious Diseases, 2015
- Interventions to improve or facilitate linkage to or retention in pre‐ART (HIV) care and initiation of ART in low‐ and middle‐income settings – a systematic reviewJournal of the International AIDS Society, 2014
- Non-adherence to antiretroviral treatment and unplanned treatment interruption among people living with HIV/AIDS in Cameroon: Individual and healthcare supply-related factorsSocial Science & Medicine, 2011
- The Chinese free antiretroviral treatment program: challenges and responsesAIDS, 2007
- Current progress of China's free ART programCell Research, 2005